Teleflex Inc (TFX)
211.21
+10.15
(+5.05%)
USD |
NYSE |
Nov 01, 16:00
211.22
+0.01
(+0.00%)
After-Hours: 20:00
Teleflex Debt to Equity Ratio: 0.3924 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2024 | 0.3924 |
June 30, 2024 | 0.3769 |
March 31, 2024 | 0.3905 |
December 31, 2023 | 0.4087 |
September 30, 2023 | 0.4723 |
June 30, 2023 | 0.3697 |
March 31, 2023 | 0.3983 |
December 31, 2022 | 0.4255 |
September 30, 2022 | 0.4385 |
June 30, 2022 | 0.4454 |
March 31, 2022 | 0.4876 |
December 31, 2021 | 0.4927 |
September 30, 2021 | 0.5604 |
June 30, 2021 | 0.6659 |
March 31, 2021 | 0.7048 |
December 31, 2020 | 0.7428 |
September 30, 2020 | 0.6574 |
June 30, 2020 | 0.7786 |
March 31, 2020 | 0.7792 |
December 31, 2019 | 0.6407 |
September 30, 2019 | 0.7007 |
June 30, 2019 | 0.7998 |
March 31, 2019 | 0.8403 |
December 31, 2018 | 0.8499 |
September 30, 2018 | 0.8588 |
Date | Value |
---|---|
June 30, 2018 | 0.9172 |
March 31, 2018 | 0.8716 |
December 31, 2017 | 0.9255 |
September 30, 2017 | 0.91 |
June 30, 2017 | 0.8479 |
March 31, 2017 | 0.9414 |
December 31, 2016 | 0.483 |
September 30, 2016 | 0.4755 |
June 30, 2016 | 0.5105 |
March 31, 2016 | 0.5131 |
December 31, 2015 | 0.5272 |
September 30, 2015 | 0.5481 |
June 30, 2015 | 0.5798 |
March 31, 2015 | 0.5929 |
December 31, 2014 | 0.559 |
September 30, 2014 | 0.5376 |
June 30, 2014 | 0.5359 |
March 31, 2014 | 0.6637 |
December 31, 2013 | 0.6722 |
September 30, 2013 | 0.5298 |
June 30, 2013 | 0.5421 |
March 31, 2013 | 0.5489 |
December 31, 2012 | 0.5453 |
September 30, 2012 | 0.5518 |
June 30, 2012 | 0.571 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.3697
Minimum
Jun 2023
0.7792
Maximum
Mar 2020
0.5314
Average
0.4799
Median
Debt to Equity Ratio Benchmarks
Boston Scientific Corp | 0.5187 |
Haemonetics Corp | 1.352 |
Globus Medical Inc | 0.1083 |
Edwards Lifesciences Corp | 0.0803 |
Halozyme Therapeutics Inc | 3.323 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 7.486B |
Total Liabilities (Quarterly) | 3.005B |
Shareholders Equity (Quarterly) | 4.482B |
Current Ratio | 2.423 |
Net Debt Paydown Yield | -0.35% |